Drugs / RIST4271
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05023811 | Aug → Sep 2021 | — | Aristea Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RIST4271 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05023811 ↗ |
| Route | Oral | “Following a Single Oral Dose” NCT05023811 ↗ |